Isatin oximes as inhibitors of respiratory syncytial virus fusion

被引：0
|
作者：
Venables, BL
Yu, KL
Pearce, BC
Zhang, Y
Combrink, K
Thuring, J
Wang, XA
Civiello, RL
Gulgeze, HB
Genovese, E
Cianci, C
Kadow, KF
Voss, S
Lamb, L
Medina, I
Clark, JM
Yang, Z
Zadjura, L
Huang, S
Krystal, M
Meanwell, NA
机构：
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Chem, Wallingford, CT 06492 USA
[2] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Virol, Wallingford, CT 06492 USA
[3] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Metab & Pharmacokinet, Wallingford, CT 06492 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2005年 / 230卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：U2609 / U2609
页数：1
相关论文
共 50 条
  • [1] Respiratory syncytial virus fusion inhibitors. Part 7: Structure-activity relationships associated with a series of isatin oximes that demonstrate antiviral activity in vivo
    Sin, Ny
    Venables, Brian L.
    Combrink, Keith D.
    Gulgeze, H. Belgin
    Yu, Kuo-Long
    Civiello, Rita L.
    Thuring, Jan
    Wang, X. Alan
    Yang, Zheng
    Zadjura, Lisa
    Marino, Anthony
    Kadow, Kathleen F.
    Cianci, Christopher W.
    Clarke, Junius
    Genovesi, Eugene V.
    Medina, Ivette
    Lamb, Lucinda
    Krystal, Mark
    Meanwell, Nicholas A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (16) : 4857 - 4862
  • [2] Molecular mechanism of respiratory syncytial virus fusion inhibitors
    Battles, Michael B.
    Langedijk, Johannes P.
    Furmanova-Hollenstein, Polina
    Chaiwatpongsakorn, Supranee
    Costello, Heather M.
    Kwanten, Leen
    Vranckx, Luc
    Vink, Paul
    Jaensch, Steffen
    Jonckers, Tim H. M.
    Koul, Anil
    Arnoult, Eric
    Peeples, Mark E.
    Roymans, Dirk
    McLellan, Jason S.
    NATURE CHEMICAL BIOLOGY, 2016, 12 (02) : 87 - +
  • [3] Molecular mechanism of respiratory syncytial virus fusion inhibitors
    Battles M.B.
    Langedijk J.P.
    Furmanova-Hollenstein P.
    Chaiwatpongsakorn S.
    Costello H.M.
    Kwanten L.
    Vranckx L.
    Vink P.
    Jaensch S.
    Jonckers T.H.M.
    Koul A.
    Arnoult E.
    Peeples M.E.
    Roymans D.
    McLellan J.S.
    Nature Chemical Biology, 2016, 12 (2) : 87 - 93
  • [4] Novel and specific respiratory syncytial virus inhibitors that target virus fusion
    Ding, WD
    Mitsner, B
    Krishnamurthy, G
    Aulabaugh, A
    Hess, CD
    Zaccardi, J
    Cutler, M
    Feld, B
    Gazumyan, A
    Raifeld, Y
    Nikitenko, A
    Lang, SA
    Gluzman, Y
    O'Hara, B
    Ellestad, GA
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (15) : 2671 - 2675
  • [5] Accelerated Discovery of Potent Fusion Inhibitors for Respiratory Syncytial Virus
    Pribut, Nicole
    Kaiser, Thomas M.
    Wilson, Robert J.
    Jecs, Edgars
    Dentmon, Zackery W.
    Pelly, Stephen C.
    Sharma, Savita
    Bartsch, Perry W., III
    Burger, Pieter B.
    Hwang, Soyon S.
    Le, Thalia
    Sourimant, Julien
    Yoon, Jeong-Joong
    Plemper, Richard K.
    Liotta, Dennis C.
    ACS INFECTIOUS DISEASES, 2020, 6 (05): : 922 - 929
  • [6] Two novel fusion inhibitors of human respiratory syncytial virus
    Lundin, Anna
    Bergstrom, Tomas
    Bendrioua, Loubna
    Kann, Nina
    Adamiak, Beata
    Trybala, Edward
    ANTIVIRAL RESEARCH, 2010, 88 (03) : 317 - 324
  • [7] Inhibitors of Respiratory Syncytial Virus
    Carter, Malcolm
    Cockerill, G. Stuart
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 43, 2008, 43 : 229 - +
  • [8] Respiratory syncytial virus - the discovery and optimization of orally bioavailable fusion inhibitors
    Meanwell, Nicholas A.
    Krystal, Mark
    DRUGS OF THE FUTURE, 2007, 32 (05) : 441 - 455
  • [9] Discovery of Piperazinylquinoline Derivatives as Novel Respiratory Syncytial Virus Fusion Inhibitors
    Zheng, Xiufang
    Wang, Lisha
    Wang, Baoxia
    Miao, Kun
    Xiang, Kunlun
    Feng, Song
    Gao, Lu
    Shen, Hong C.
    Yun, Hongying
    ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (06): : 558 - 562
  • [10] Prospects for the development of fusion inhibitors to treat human respiratory syncytial virus infection
    Bonfanti, Jean-Francois
    Roymans, Dirk
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2009, 12 (04) : 479 - 487
12345